Free Trial

electroCore Q1 2023 Earnings Report

electroCore logo
$15.27 +0.75 (+5.17%)
(As of 12/20/2024 05:31 PM ET)

electroCore Earnings Headlines

HC Wainwright Forecasts Stronger Earnings for electroCore
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share
The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.
NeuroMetrix, Inc.: NeuroMetrix to be Acquired by electroCore
electroCore donates gammaCore Sapphire for real world evalution of nVNS
See More electroCore Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like electroCore? Sign up for Earnings360's daily newsletter to receive timely earnings updates on electroCore and other key companies, straight to your email.

About electroCore

electroCore (NASDAQ:ECOR), a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

View electroCore Profile

More Earnings Resources from MarketBeat

Upcoming Earnings